Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent
First Claim
1. An orally administerable galenic formulation allowing improved absorption by the transmembrane or paracellular route in the gastrointestinal tract, comprisingat least one active ingredient which is a guanidine or a guanylguanidine, an absorption-promoting agent having an HLB greater than 8 which is one or more lipid substances selected from polysorbates, ethers of polyoxyethylene and alkyl, esters of polyoxyethylene and fatty acids, fatty acids, fatty alcohols, bile acids and their salts with pharmaceutically acceptable cations, esters of C1-C6 alkanols with fatty acids, esters of polyol with fatty acids, wherein said polyol comprises 2 to 6 hydroxyl functional groups, and polyglycolysed glycerides, and one or more pharmaceutically acceptable excipients.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates to an orally administrable galenic form allowing improved absorption by the transmembrane or paracellular route in the gastrointestinal tract of active ingredients which are hydrophilic or ionizable in physiol. media, comprising at least one such active ingredient, an absorption-promoting agent having an HLB>8, the the absorption-promoting agent consisting of one or more lipid substances chosen from: polysorbates; polyoxyethylene ethers; esters of polyoxyethylene and fatty acids; fatty acids; fatty alcs.; bile acids and their salts with pharmaceutically acceptable cations; esters of C1-C6 alkanol with fatty acids; esters of polyol with fatty acids, the polyol comprising from 2 to 6 hydroxyl functional groups; and polyglycolyzed glycerides; in combination with one or more pharmaceutically acceptable excipients, the pharmaceutical forms comprising captopril being excluded. A controlled-release tablet contained (1) cores contg. calcium acamprosate 50, Gelucire 44/14 10, Compritol 10, microcryst. cellulose 19, Povidone 10, and Mg stearate 1% and (2) a film-coating compn. contg. HPMC 64, PEG-4000 15, and talc 21%.
-
Citations
28 Claims
-
1. An orally administerable galenic formulation allowing improved absorption by the transmembrane or paracellular route in the gastrointestinal tract, comprising
at least one active ingredient which is a guanidine or a guanylguanidine, an absorption-promoting agent having an HLB greater than 8 which is one or more lipid substances selected from polysorbates, ethers of polyoxyethylene and alkyl, esters of polyoxyethylene and fatty acids, fatty acids, fatty alcohols, bile acids and their salts with pharmaceutically acceptable cations, esters of C1-C6 alkanols with fatty acids, esters of polyol with fatty acids, wherein said polyol comprises 2 to 6 hydroxyl functional groups, and polyglycolysed glycerides, and one or more pharmaceutically acceptable excipients.
Specification